Novo notes 2017 corporate venturing results

Mar 29, 2018 • Callum Cyrus

The pharmaceutical company injected more than $2bn into life science businesses in 2017 and recorded 14 exits.

Denmark-based pharmaceutical firm Novo will intensify its life science investments after generating DKK56bn ($9.3bn) in income and investment returns from its non-Novo investment portfolio in 2017.

The corporate, which operates subsdiaries Novo Ventures and Novo Seeds, provided approximately $2.3bn in pre and post-IPO funding for companies in 2017, including investments in Genoa Pharmaceuticals, E-Scape Bio and Northsea Therapeutics.

Novo also provided funding for publicly-listed portfolio companies including drug development alliance Evotec, laboratory diagnostics services provider Synlab and medical product supplier ConvaTec,…

LEADERSHIP SOCIETY

Informing, connecting, and transforming the global corporate venture capital ecosystem.
The Global Corporate Venturing (GCV) Leadership Society’s mission is to help bridge the different strengths and ambitions of investors across industry sectors, geography, structure, and their returns.

Find out more

FUNDING ROUND DATA

Which corporates are backing which startups? Search our corporate deal database.

CVC DIRECTORY

Find details about global CVC units in the CVC Directory

SPECIAL REPORT

Finding a new path: How venture units guide corporations through transformational change

Events

Webinar: Designing a winning CVC platform – Engagement, venture development, operations

Jan 15, 2025
Online

Find out more All events

Events

GCV Institute: CVC Investment Programs

Jan 28 -
Jan 29, 2025
Online

Find out more All events

Events

GCV Institute: CVC Investment Programs

Mar 17 -
Mar 18, 2025
Palo Alto, CA (USA)

Find out more All events

Events

GCVI Summit 2025

Mar 18 -
Mar 20, 2025
Monterey, CA (USA)

Find out more All events

Events

GCV Institute: Landing the Value of Corporate Venturing

May 1 -
May 6, 2025
Online

Find out more All events

Events

GCV Symposium 2025

Jun 17 -
Jun 19, 2025
London (UK)

Find out more All events

About us

GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.